HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 19, 2013, Pages 7542-7549

  Kho, Eun Young ^a   Wang, Hsu Kun ^a   Banerjee, N Sanjib ^a   Broker, Thomas R ^a   Chow, Louise T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

HPV transcripts; Human papillomavirus DNA amplification; Trans complementation

Indexed keywords

CRE RECOMBINASE; MUTANT PROTEIN; PROTEIN E6; PROTEIN P53; SMALL INTERFERING RNA; VIRUS DNA; VIRUS RNA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA RECOMBINATION; EPITHELIUM CELL; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; KERATINOCYTE; LOXP SITE; MISSENSE MUTATION; NONHUMAN; NULL ALLELE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; VIRUS CULTURE; VIRUS MUTANT;

HPV TRANSCRIPTS; HUMAN PAPILLOMAVIRUS DNA AMPLIFICATION; TRANS COMPLEMENTATION;

CELLS, CULTURED; DNA, VIRAL; DNA-BINDING PROTEINS; GENES, P53; GENES, TUMOR SUPPRESSOR; GENETIC COMPLEMENTATION TEST; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 18; HUMANS; INTEGRASES; KERATINOCYTES; MUTATION; MUTATION, MISSENSE; ONCOGENE PROTEINS, VIRAL; PHENOTYPE; PLASMIDS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84877341253     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1304855110     Document Type: Article

References (48)

1. de Villiers E-M, Fauquet C, Broker TR, Bernard H-U, zur Hausen H (2004) Classification of papillomaviruses. Virology 324(1): 17-27.
2. zur Hausen H (2009) Papillomaviruses in the causation of human cancers - a brief historical account. Virology 384(2): 260-265.
3. Chow LT, Broker TR, Steinberg BM (2010) The natural history of human papillomavirus infections of the mucosal epithelia. APMIS 118(6-7): 422-449.
4. Zhang B, Chen W, Roman A (2006) The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci USA 103(2): 437-442.
5. Genovese NJ, Banerjee NS, Broker TR, Chow LT (2008) Casein kinase II motifdependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes. J Virol 82(10): 4862-4873.
6. McLaughlin-Drubin ME, Münger K (2009) The human papillomavirus E7 oncoprotein. Virology 384(2): 335-344.
7. Zimmermann H, Degenkolbe R, Bernard H-U, O'Connor MJ (1999) The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol 73(8): 6209-6219.
8. Kumar A, et al. (2002) Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Mol Cell Biol 22(16): 5801-5812.
9. Thomas MC, Chiang CM (2005) E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol Cell 17(2): 251-264.
10. Patel D, Huang SM, Baglia LA, McCance DJ (1999) The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J 18(18): 5061-5072.
11. Kruse JP, Gu W (2009) Modes of p53 regulation. Cell 137(4): 609-622.
12. Howie HL, Katzenellenbogen RA, Galloway DA (2009) Papillomavirus E6 proteins. Virology 384(2): 324-334.
13. Pim D, Tomaic V, Banks L (2009) The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein. J Virol 83(19): 9863-9874.
14. Lepik D, Ilves I, Kristjuhan A, Maimets T, Ustav M (1998) p53 protein is a suppressor of papillomavirus DNA amplificational replication. J Virol 72(8): 6822-6831.
15. Massimi P, Pim D, Bertoli C, Bouvard V, Banks L (1999) Interaction between the HPV-16 E2 transcriptional activator and p53. Oncogene 18(54): 7748-7754.
16. Brown C, Kowalczyk AM, Taylor ER, Morgan IM, Gaston K (2008) P53 represses human papillomavirus type 16 DNA replication via the viral E2 protein. Virol J 5:5.
17. Jian Y, et al. (1998) Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes. Oncogene 17(16): 2027-2038.
18. Demers GW, Halbert CL, Galloway DA (1994) Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology 198(1): 169-174.
19. Eichten A, Westfall M, Pietenpol JA, Münger K (2002) Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein. Virology 295(1): 74-85.
20. Thomas JT, Hubert WG, Ruesch MN, Laimins LA (1999) Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc Natl Acad Sci USA 96(15): 8449-8454.
21. Lee C, Wooldridge TR, Laimins LA (2007) Analysis of the roles of E6 binding to E6TP1 and nuclear localization in the human papillomavirus type 31 life cycle. Virology 358(1): 201-210.
22. Wang HK, Duffy AA, Broker TR, Chow LT (2009) Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev 23(2): 181-194.
23. Pim D, Banks L (1999) HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6. Oncogene 18(52): 7403-7408.
24. Crook T, Tidy JA, Vousden KH (1991) Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67(3): 547-556.
25. Foster SA, Demers GW, Etscheid BG, Galloway DA (1994) The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J Virol 68(9): 5698-5705.
26. Liu Y, et al. (1999) Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J Virol 73(9): 7297-7307.
27. Noya F, Chien WM, Broker TR, Chow LT (2001) p21cip1 Degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7. J Virol 75(13): 6121-6134.
28. Yan W, Chen X (2006) GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner. J Biol Chem 281(12): 7856-7862.
29. Chow LT, Broker TR (2006) Human papillomavirus RNA transcription. The Papillomaviruses, eds Garcea RL, DiMaio D (Springer, New York), pp 109-144.
30. Wang X, Meyers C, Wang HK, Chow LT, Zheng ZM (2011) Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol 85(16): 8080-8092.
31. Chiang CM, Broker TR, Chow LT (1991) An E1M - E2C fusion protein encoded by human papillomavirus type 11 is asequence-specific transcription repressor. J Virol 65(6): 3317-3329.
32. Banerjee NS, Wang HK, Broker TR, Chow LT (2011) Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes. J Biol Chem 286(17): 15473-15482.
33. Park RB, Androphy EJ (2002) Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J Virol 76(22): 11359-11364.
34. Hubert WG, Laimins LA (2002) Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression. J Virol 76(5): 2263-2273.
35. Spangle JM, Münger K (2010) The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol 84(18): 9398-9407.
36. Lu Z, et al. (2004) Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin. J Biol Chem 279(34): 35664-35670.
37. Shahbazian D, Parsyan A, Petroulakis E, Hershey J, Sonenberg N (2010) eIF4B controls survival and proliferation and is regulated by proto-oncogenic signaling pathways. Cell Cycle 9(20): 4106-4109.
38. O'Shea C, et al. (2005) Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication. EMBO J 24(6): 1211-1221.
39. Pim D, Massimi P, Dilworth SM, Banks L (2005) Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A. Oncogene 24(53): 7830-7838.
40. Menges CW, Baglia LA, Lapoint R, McCance DJ (2006) Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res 66(11): 5555-5559.
41. Suprynowicz FA, et al. (2010) The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification. J Virol 84(20): 10619-10629.
42. Khan J, et al. (2011) Role of calpain in the formation of human papillomavirus type 16 E1-E4 amyloid fibers and reorganization of the keratin network. J Virol 85(19): 9984-9997.
43. Burnett S, Jareborg N, DiMaio D (1992) Localization of bovine papillomavirus type 1 E5 protein to transformed basal keratinocytes and permissive differentiated cells in fibropapilloma tissue. Proc Natl Acad Sci USA 89(12): 5665-5669.
44. Morgenstern JP, Land H (1990) Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18(12): 3587-3596.
45. Hardouin N, Nagy A (2000) Gene-trap-based target site for cre-mediated transgenic insertion. Genesis 26(4): 245-252.
46. Banerjee NS, Chow LT, Broker TR (2005) Retrovirus-mediated gene transfer to analyze HPV gene regulation and protein functions in organotypic "raft" cultures. Methods Mol Med 119: 187-202.
47. Van Tine BA, Broker TR, Chow LT (2005) Simultaneous in situ detection of RNA, DNA, and protein using tyramide-coupled immunofluorescence. Methods Mol Biol 292: 215-230.
48. Jha S, et al. (2010) Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway. Mol Cell 38(5): 700-711.